Detalhe da pesquisa
1.
Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.
Prostate
; 82(13): 1284-1292, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747943
2.
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting.
Eur J Nucl Med Mol Imaging
; 49(3): 1041-1051, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463809
3.
Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.
Prostate
; 79(10): 1106-1116, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045266
4.
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.
Prostate
; 77(8): 849-858, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295408
5.
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer.
Prostate
; 77(5): 479-488, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27990667
6.
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
Cancer
; 121(21): 3853-61, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26178426
7.
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.
Lancet Oncol
; 13(11): 1105-13, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23059047
8.
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer.
Nucl Med Mol Imaging
; 56(4): 188-195, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846415
9.
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 20(3): 270-277, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279418
10.
aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer.
J Nucl Med
; 63(2): 233-239, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049980
11.
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.
Lancet
; 375(9724): 1437-46, 2010 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20398925
12.
A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection.
Scand J Urol
; 55(4): 293-297, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939583
13.
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.
BJU Int
; 105(4): 462-7, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19624594
14.
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.
Clin Cancer Res
; 15(6): 2091-7, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19276271
15.
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients.
J Nucl Med
; 61(5): 671-675, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31586004
16.
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Clin Chem
; 55(4): 765-73, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19233911
17.
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Nat Med
; 25(12): 1928-1937, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768066
18.
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Clin Cancer Res
; 13(23): 7053-8, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056182
19.
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Clin Cancer Res
; 13(7): 2023-9, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17404082
20.
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 4(7): 944-951, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799999